MLchartDataset catalogue

D-1MT

Term · Oncology and biomedicine · MLC-T-ONC-002259

A substance being studied in the treatment of melanoma and many other types of cancer. D-1MT blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving D-1MT to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called 1-methyl-d-tryptophan.

Table 1. Record
IdentifierMLC-T-ONC-002259
FieldOncology and biomedicine
Expansions1-methyl-d-tryptophan
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002259",
  "term": "D-1MT",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of melanoma and many other types of cancer. D-1MT blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving D-1MT to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called 1-methyl-d-tryptophan.",
  "expansions": [
    "1-methyl-d-tryptophan"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/d-1mt/"
}

Record 5,639 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.